HCG, Free β-Subunit, and β-Core Fragment as Markers of Malignancies

Human Chorionic Gonadotropin (hCG)

Volumn , Issue , 2010, Pages 339-344

  Cole, Laurence A ^a  

^a USA hCG Reference Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882466598     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384907-6.00032-3     Document Type: Chapter

References (29)

1. Butler SA, Ikram MS, Mathieu S, Iles RK The increase in bladder carcinoma cell population induced by the free beta subunit of hCG is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer 2000, 82:1553-1556.
2. Iles RK Ectopic hCGβ expression by epithelial cancer: malignant behavior metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol 2007, 260:264-270.
3. Carter WB, Sekharem M, Coppola D Human chorionic gonadotropin induces apoptosis in breast cancer. Breast Cancer Res Treat 2006, 100:S243-S244.
4. Iles RK hCG beta expression by cervical squamous carcinoma-in vivo histological association with tumour invasion and apoptosis. Histopathology 2008, 53:147-155.
5. Crawford RA, Iles RK, Carter PG, Caldwell CJ, Shepherd JH, Chard T The prognostic significance of beta human chorionic gonadotropin and its metabolites in women with cervical carcinoma. J Clin Pathol 1998, 51:685-688.
6. Delves PJ, Iles RK, Roitt IM, Lund T Designing a new generation of anti-hCG vaccines for cancer therapy. Mol Cell Endocrinol 2007, 260:276-281.
7. Iversen PL, Mourich DV, Moulton HM Monoclonal antibodies to two epitopes of β-human chorionic gonadotropin for the treatment of cancer. Curr Opin Mol Ther 2003, 5:156-160.
8. Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL Active specific immunotherapy with β-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res 2002, 8:2044-2051.
9. Acevedo HF, Tong JY, Hartsock RJ Human chorionic gonadotropin-beta subunit gene statement in cultured human fetal and cancer cells of different types and origins. Cancer 1995, 76:1467-1475.
10. Acevedo HF, Hartstock RJ Metastatic phenotype correlates with high expression of membrane-associated complete β-human chorionic gonadotropin in vivo. Cancer 1996, 78:2388-2399.
11. Muller C, Cole LA The quagmire of hCG and hCG testing in gynecologic oncology. Gynecol Oncol 2009, 112:663-672.
12. Cole LA New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 2009, 7:1-37.
13. Cole LA β-core fragment (β-core UGP or UGF). Tumor Marker Update 1994, 6:69-75.
14. Nishimura R, Baba S, Hasegawa K, Kinugasa M, Okamura M, Kimura A, et al. Characterization of immunoreactive hCG beta-subunit in cultured fluids of the cell lines derived from gynecologic malignant tumors. Nippon Sanka Fujinka Gakkai Zasshi 1990, 42:1471-1476.
15. Marcillac I, Cottu P, Theodore C, Terrier-Lacombe MJ, Bellet D, Droz JP Free hCG beta subunit as tumour marker in urothelial cancer. Lancet 1993, 341:1354-1355.
16. Bepler G, Jaques G, Oie HK, Gazdar AF Human chorionic gonadotropin and related glycoprotein hormones in lung cancer cell lines. Cancer Lett 1991, 58:145-150.
17. Offner FA, Ott G, Povey S, Knuechel R, Preisler V, Fuezesi L, et al. Characterization of the new bladder cancer cell line HOK-1: expression of transitional squamous and glandular differentiation. Virchow Arch 1991, 428:99-106.
18. Ozturk M, Bellet D, Isselbacher KJ, Wands J Ectopic beta-human chorionic gonadotropin production by a human hepatoma cell line (FOCUS): isolation and immunochemical characterization. Endocrinol 1987, 120:559-566.
19. Rosen SW, Calvert I, Weintraub BD, Tseng JS, Rabson AS Stimulation of N6O2'-dibutyryl cyclic adenosine 3':5'-monophosphate of ectopic production of the free beta subunit of chorionic gonadotropin by a human brain tumor cell line. Cancer Res 1980, 40:4325-4328.
20. Udagawa Y, Nozawa S, Chin K, Sakayori M, Mikami M, Ohta K, et al. Biological properties of two newly established cell lines (SKG- 3a,3b) from a human uterine cervical epidermoid carcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1984, 36:237-246.
21. Cole LA, Hartle RJ, Laferla JJ, Ruddon RW Detection of the free β subunit of human chorionic gonadotropin in cultures of normal and malignant trophoblast cells, pregnancy sera, and sera of patients with choriocarcinoma. Endocrinol 1983, 113:1176-1178.
22. Iles RK Human chorionic gonadotropin and its fragments as markers of prognosis in bladder cancer. Tumor Marker Update 1995, 7:161-166.
23. Cole LA, Schwartz PE, Wong Y Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system: I sensitivity and specificity comparison with other markers. Gynecol Oncol 1988, 31:82-90.
24. Regelson W Have we found the "definitive cancer biomarker"? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta statement as a key to malignancy. Cancer 1995, 76:1299-1301.
25. Butler SA, Iles RK Ectopic human chorionic gonadotropin β secretion by epithelial tumors and human chorionic gonadotropin β-induced apoptosis in karposi's sarcoma: is there a connection?. Clin Cancer Res 2003, 9:4666-4673.
26. Szturmowicz M, Slodkowska J, Zych J, Rudzinski P, Sakowicz A, Rowinska-Zakrzewska E Frequency and clinical significance of β-subunit human chorionic gonadotropin expression in non-small cell lung cancer patients. Tumor Biol 1999, 20:99-104.
27. Cook AM, Huddart RA, Jay G, Norman A, Dearnaley DP, Horwich A The utility of tumor markers in assessing the response to chemotherapy in advanced bladder cancer. Br J Cancer 2000, 82:1952-1957.
28. Kinugasa M, Nishimura R, Koizumi T, Morisue K, Higashida T, Natazuka T, et al. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers. Jpn J Cancer Res 1995, 86:783-789.
29. Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, et al. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report. Gynecol Oncol 1996, 60:264-270.